10x Genomics, Inc.
MX ˙ BMV ˙ US88025U1097
SecurityMX:TXG / 10x Genomics, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership1,048,005 shares
Latest Disclosed Value $ 22,249,147
Northern Trust Corp reports 5.50% increase in ownership of TXG / 10x Genomics, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 1,048,005 shares of 10x Genomics, Inc. (MX:TXG) valued at $22,249,147 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 993,380 shares of 10x Genomics, Inc.. This represents a change in shares of 5.50% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F 10X GENOMICS CL A COM 88025U109 1,048,005 54,625 5.50 22,249 37.32 0.0029
2026-02-17 2025-12-31 13F 10X GENOMICS CL A COM 88025U109 993,380 -45,883 -4.41 16,202 33.37 0.0021
2025-11-14 2025-09-30 13F 10X GENOMICS CL A COM 88025U109 1,039,263 29,951 2.97 12,149 3.94 0.0016
2025-08-13 2025-06-30 13F 10X GENOMICS CL A COM 88025U109 1,009,312 460,280 83.83 11,688 143.83 0.0016
2025-05-13 2025-03-31 13F 10X GENOMICS CL A COM 88025U109 549,032 -12,634 -2.25 4,793 -40.57 0.0007
2025-02-14 2024-12-31 13F 10X GENOMICS CL A COM 88025U109 561,666 -31,923 -5.38 8,066 -39.83 0.0011
2024-11-13 2024-09-30 13F 10X GENOMICS COM 88025U109 593,589 -55,221 -8.51 13,403 6.21 0.0022
2024-08-14 2024-06-30 13F 10X GENOMICS COM 88025U109 648,810 56,948 9.62 12,619 -43.19 0.0021
2024-05-14 2024-03-31 13F 10X GENOMICS COM 88025U109 591,862 122,227 26.03 22,213 -15.48 0.0038
2024-02-13 2023-12-31 13F 10X GENOMICS COM 88025U109 469,635 -2,450 -0.52 26,281 34.96 0.0048
2023-11-13 2023-09-30 13F 10X GENOMICS COM 88025U109 472,085 11,599 2.52 19,474 -24.27 0.0038
2023-08-11 2023-06-30 13F 10X GENOMICS COM 88025U109 460,486 3,835 0.84 25,714 0.93 0.0049
2023-05-15 2023-03-31 13F 10X GENOMICS COM 88025U109 456,651 58,937 14.82 25,477 75.79 0.0051
2023-02-13 2022-12-31 13F 10X GENOMICS COM 88025U109 397,714 4,779 1.22 14,493 29.51 0.0030
2022-11-14 2022-09-30 13F 10X GENOMICS COM 88025U109 392,935 6,341 1.64 11,190 -36.03 0.0026
2022-08-12 2022-06-30 13F 10X GENOMICS COM 88025U109 386,594 -88,125 -18.56 17,493 -51.56 0.0037
2022-05-13 2022-03-31 13F 10X GENOMICS COM 88025U109 474,719 5,285 1.13 36,113 -48.36 0.0064
2022-02-08 2021-12-31 13F 10X GENOMICS COM 88025U109 469,434 -50,359 -9.69 69,926 -7.59 0.0115
2021-11-15 2021-09-30 13F 10X GENOMICS COM 88025U109 519,793 42,144 8.82 75,672 -19.10 0.0134
2021-08-13 2021-06-30 13F 10X GENOMICS CL A COM 88025U109 477,649 68,786 16.82 93,533 26.39 0.0165
2021-05-12 2021-03-31 13F 10X GENOMICS CL A COM 88025U109 408,863 13,132 3.32 74,003 32.06 0.0138
2021-02-11 2020-12-31 13F 10X GENOMICS CL A COM 88025U109 395,731 107,242 37.17 56,036 55.79 0.0109
2020-11-16 2020-09-30 13F 10X GENOMICS CL A COM 88025U109 288,489 105,361 57.53 35,968 119.91 0.0079
2020-08-14 2020-06-30 13F 10X GENOMICS COM 88025U109 183,128 158,666 648.62 16,356 973.23 0.0039
2020-05-14 2020-03-31 13F 10X GENOMICS COM 88025U109 24,462 1,777 7.83 1,524 -11.91 0.0004
2020-02-14 2019-12-31 13F 10X GENOMICS COM 88025U109 22,685 14,471 176.17 1,730 317.87 0.0004
2019-11-13 2019-09-30 13F 10X GENOMICS CL A COM 88025U109 8,214 8,214 414 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.